Cargando…
Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a persistent environmental contaminant that induces the progression of steatosis to steatohepatitis with fibrosis in mice. Furthermore, TCDD reprograms hepatic metabolism by redirecting glycolytic intermediates while inhibiting lipid metabolism. Here, we...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011583/ https://www.ncbi.nlm.nih.gov/pubmed/36914879 http://dx.doi.org/10.1038/s41598-023-31087-9 |
_version_ | 1784906426962935808 |
---|---|
author | Cholico, Giovan N. Orlowska, Karina Fling, Russell R. Sink, Warren J. Zacharewski, Nicholas A. Fader, Kelly A. Nault, Rance Zacharewski, Tim |
author_facet | Cholico, Giovan N. Orlowska, Karina Fling, Russell R. Sink, Warren J. Zacharewski, Nicholas A. Fader, Kelly A. Nault, Rance Zacharewski, Tim |
author_sort | Cholico, Giovan N. |
collection | PubMed |
description | 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a persistent environmental contaminant that induces the progression of steatosis to steatohepatitis with fibrosis in mice. Furthermore, TCDD reprograms hepatic metabolism by redirecting glycolytic intermediates while inhibiting lipid metabolism. Here, we examined the effect of TCDD on hepatic acetyl-coenzyme A (acetyl-CoA) and β-hydroxybutyrate levels as well as protein acetylation and β-hydroxybutyrylation. Acetyl-CoA is not only a central metabolite in multiple anabolic and catabolic pathways, but also a substrate used for posttranslational modification of proteins and a surrogate indicator of cellular energy status. Targeted metabolomic analysis revealed a dose-dependent decrease in hepatic acetyl-CoA levels coincident with the phosphorylation of pyruvate dehydrogenase (E1), and the induction of pyruvate dehydrogenase kinase 4 and pyruvate dehydrogenase phosphatase, while repressing ATP citrate lyase and short-chain acyl-CoA synthetase gene expression. In addition, TCDD dose-dependently reduced the levels of hepatic β-hydroxybutyrate and repressed ketone body biosynthesis gene expression. Moreover, levels of total hepatic protein acetylation and β-hydroxybutyrylation were reduced. AMPK phosphorylation was induced consistent with acetyl-CoA serving as a cellular energy status surrogate, yet subsequent targets associated with re-establishing energy homeostasis were not activated. Collectively, TCDD reduced hepatic acetyl-CoA and β-hydroxybutyrate levels eliciting starvation-like conditions despite normal levels of food intake. |
format | Online Article Text |
id | pubmed-10011583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-100115832023-03-15 Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver Cholico, Giovan N. Orlowska, Karina Fling, Russell R. Sink, Warren J. Zacharewski, Nicholas A. Fader, Kelly A. Nault, Rance Zacharewski, Tim Sci Rep Article 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a persistent environmental contaminant that induces the progression of steatosis to steatohepatitis with fibrosis in mice. Furthermore, TCDD reprograms hepatic metabolism by redirecting glycolytic intermediates while inhibiting lipid metabolism. Here, we examined the effect of TCDD on hepatic acetyl-coenzyme A (acetyl-CoA) and β-hydroxybutyrate levels as well as protein acetylation and β-hydroxybutyrylation. Acetyl-CoA is not only a central metabolite in multiple anabolic and catabolic pathways, but also a substrate used for posttranslational modification of proteins and a surrogate indicator of cellular energy status. Targeted metabolomic analysis revealed a dose-dependent decrease in hepatic acetyl-CoA levels coincident with the phosphorylation of pyruvate dehydrogenase (E1), and the induction of pyruvate dehydrogenase kinase 4 and pyruvate dehydrogenase phosphatase, while repressing ATP citrate lyase and short-chain acyl-CoA synthetase gene expression. In addition, TCDD dose-dependently reduced the levels of hepatic β-hydroxybutyrate and repressed ketone body biosynthesis gene expression. Moreover, levels of total hepatic protein acetylation and β-hydroxybutyrylation were reduced. AMPK phosphorylation was induced consistent with acetyl-CoA serving as a cellular energy status surrogate, yet subsequent targets associated with re-establishing energy homeostasis were not activated. Collectively, TCDD reduced hepatic acetyl-CoA and β-hydroxybutyrate levels eliciting starvation-like conditions despite normal levels of food intake. Nature Publishing Group UK 2023-03-13 /pmc/articles/PMC10011583/ /pubmed/36914879 http://dx.doi.org/10.1038/s41598-023-31087-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Cholico, Giovan N. Orlowska, Karina Fling, Russell R. Sink, Warren J. Zacharewski, Nicholas A. Fader, Kelly A. Nault, Rance Zacharewski, Tim Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver |
title | Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver |
title_full | Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver |
title_fullStr | Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver |
title_full_unstemmed | Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver |
title_short | Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver |
title_sort | consequences of reprogramming acetyl-coa metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011583/ https://www.ncbi.nlm.nih.gov/pubmed/36914879 http://dx.doi.org/10.1038/s41598-023-31087-9 |
work_keys_str_mv | AT cholicogiovann consequencesofreprogrammingacetylcoametabolismby2378tetrachlorodibenzopdioxininthemouseliver AT orlowskakarina consequencesofreprogrammingacetylcoametabolismby2378tetrachlorodibenzopdioxininthemouseliver AT flingrussellr consequencesofreprogrammingacetylcoametabolismby2378tetrachlorodibenzopdioxininthemouseliver AT sinkwarrenj consequencesofreprogrammingacetylcoametabolismby2378tetrachlorodibenzopdioxininthemouseliver AT zacharewskinicholasa consequencesofreprogrammingacetylcoametabolismby2378tetrachlorodibenzopdioxininthemouseliver AT faderkellya consequencesofreprogrammingacetylcoametabolismby2378tetrachlorodibenzopdioxininthemouseliver AT naultrance consequencesofreprogrammingacetylcoametabolismby2378tetrachlorodibenzopdioxininthemouseliver AT zacharewskitim consequencesofreprogrammingacetylcoametabolismby2378tetrachlorodibenzopdioxininthemouseliver |